2 янв. 2024 г. · By the 1-year landmark analysis, clopidogrel was numerically, but not significantly, superior to aspirin for cardiovascular events (6.79% and ...

By the 1-year landmark analysis, clopidogrel was numerically, but not significantly, superior to aspirin for cardiovascular events (6.79% and 8.68%, ... Skip main navigation · Abstract · Methods · Results

Clopidogrel monotherapy was noninferior, but not superior, to aspirin monotherapy for net adverse clinical events beyond 1 year after PCI by the landmark ...

By the 1-year landmark analysis, clopidogrel was numerically, but not significantly, superior to aspirin for cardiovascular events (6.79% and 8.68%, ...

23 нояб. 2023 г. · By the 1-year landmark analysis, clopidogrel was numerically, but not significantly, superior to aspirin for cardiovascular events (6.79% and ...

Aspirin monotherapy compared with clopidogrel monotherapy was associated with similar cardiovascular and bleeding outcomes beyond 1 month and up to 1 year after ... Abstract · Introduction · Methods · Results

3 нояб. 2023 г. · The results of this study show that at 5 years clopidogrel monotherapy after one month of DAPT was non-inferior but not superior to aspirin ...

Aspirin monotherapy compared with clopidogrel monotherapy was associated with similar cardiovascular and bleeding outcomes beyond 1 month and up to 1 year after ...

31 авг. 2024 г. · Aspirin monotherapy compared to clopidogrel monotherapy was associated with similar cardiovascular and bleeding outcomes beyond 1 month and up to 1 year after ...

This study from the Chinese Fuwai Registry sought to compare the efficacy and safety of clopidogrel monotherapy versus aspirin monotherapy beyond 12 months ... Не найдено: 1 | Нужно включить: 1